- Contract Packaging
- Leaders in Packaging
Article | January 31, 1998
Incidences of sexual dysfunction by those taking Prozac, Zoloft, Paxil, and Luvox (all selective serotonin reuptake inhibitors) may be much higher than indicated on product labeling, and FDA is considering ordering labeling changes more reflective of reality.
At a meeting of FDA's Psychopharmacologic Drug Advisory Committee Prozac was cited as an example of a drug whose adverse effects are underreported on the label. After initially reporting levels of sexual dysfunction at under 1% Eli Lilly maker of Prozac now acknowledges it is 30%. One panel member however said most physicians find it to be 90%.
Related Sponsored Content
E-BOOK SPECIAL REPORT
The 2014 Trends Report
Sign up to receive timely updates from our editors and download this e-book consisting of our editors' picks of most notable package designs. Updated for 2014!